Skip to main content

Table 7 Linear Regression Model for production and dissemination of evidence*

From: Use of health systems and policy research evidence in the health policymaking in eastern Mediterranean countries: views and practices of researchers

  Production and dissemination of evidence
  Beta (Standard Error) P-Value
Constant 0.786 (0.348) 0.026
Frequency of undertaking each of these knowledge transfer and exchange activities related to contact and exchange with health policymakers and stakeholders   
   1- Interacted with credible messengers/sources (i.e., people who are not researchers but are seen by policymakers and stakeholders as credible sources of research) to promote use of evidence from HPSR and/or your own research 0.017 (0.057) 0.825
   2- Developed relationships with print, radio and/or television journalists to promote use of evidence from HPSR and/or your own research. 0.071 (0.065) 0.398
   3- Participated in meetings for presentation of results from HPSR and/or your own research to health policymakers and stakeholders. 0.172 (0.064) 0.058
   4- Tried to involve policymakers and stakeholders but had difficulty contacting them. 0.087 (0.048) 0.211
   5- Provided technical assistance to policymakers and stakeholders through short-term work through expert advisory committees, conferences, or forums. 0.033 (0.075) 0.766
   6- Provided technical assistance through long- term formal collaborations between your institution and policymakers and stakeholders for sustained technical capacity development. -0.025 (0.078) 0.824
   7- Interacted with health policymakers and stakeholders through informal conversations with personal contacts. 0.053 (0.064) 0.526
   8- Interacted with health policymakers and stakeholders as part of a priority-setting process to identify high-priority health policy issues and research themes. 0.364 (0.084) 0.001
   9- Involved policymakers and stakeholders in your research (in the development of joint proposals/research methodology and tools/analysis & write-up/publications). 0.019 (0.064) 0.833
   10- Actively participated in health policy development committees or technical committees that help in decisionmaking. 0.121 (0.059) 0.161
   11- Trained health policymakers and stakeholders to acquire, assess, interpret, and apply health research findings. 0.19 (0.057) 0.023
Investments/resources available to you for the production and transfer and exchange of evidence from HPSR   
   1. National funding is available for undertaking HPSR. 0.125 (0.064) 0.154
   2- Regional funding is available for undertaking HPSR. -0.12 (0.073) 0.181
   3- International funding is available for undertaking HPSR. 0.105 (0.074) 0.202
   4- Funding sources (e.g., granting agencies) encourage knowledge transfer and exchange activities. -0.08 (0.06) 0.234
   5- Funders formulate their priorities and calls for proposals in response to national and regional needs. 0.072 (0.063) 0.359
   6- Policymakers and stakeholders provide adequate funding for priority research. -0.049 (0.065) 0.55
   7- Policymakers and stakeholders clearly articulate priorities for health systems and policy research. -0.009 (0.076) 0.92
   8- Incentives for knowledge transfer and exchange are available (e.g., performance incentives for knowledge transfer and exchange and proper criteria of promotion) within your organization. -0.064 (0.054) 0.342
Adjusted R2 0.634  
F 11.040  
P-value < 0.001  
N 110  
  1. † Beta stands for the average change in the score of the dependant variables per unit increase in independent variable scores.
  2. * Results in bold are statistically significant at 0.05 level
  3. HPSR: health policy and systems research